Catskill Regional Medical Center announced Tuesday that it is notifying patients between 2007 and May 2013 who may have received an insulin pen injection during their visit that some insulin injection pens may have been used on more than one patient.
The hospital said it is not aware of any contamination between patients, as a precaution, it is recommending that those patients be tested for hepatitis B, hepatitis C and HIV.
Free and confidential blood testing services will be made available to those patients by calling 1-800-277-4221.
Catskill Regional is identifying the names of patients who may be impacted by this and will send them notification letters.
Hospital CEO and Chief Medical Officer Dr. Gerard Galarneau apologized to the patients and said they have taken steps to prevent a recurrence of this issue.